The company also highlighted that they have commenced the process of Orphan Drug applications to the EMA for Trofinetide in both Rett and Fragile X Syndromes.
Looking forward to the video on the company's website.
Tony
Ann: FDA grants Neuren Orphan Drug designation for Rett syndrome, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.70 |
Change
1.160(9.25%) |
Mkt cap ! $1.702B | |||
| Open | High | Low | Value | Volume |
| $12.96 | $14.00 | $12.91 | $9.679M | 707.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 676 | $13.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.70 | 89 | 4 |
View Market Depth
| Last trade - 12.53pm 26/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |